- Report
- June 2026
- 287 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 298 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- June 2026
- 180 Pages
Global
From €5317EUR$5,850USD£4,586GBP
- Report
- April 2026
- 115 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- January 2026
- 160 Pages
Global
From €3590EUR$3,950USD£3,096GBP
- Report
- April 2026
- 120 Pages
Global
From €3500EUR$4,125USD£3,124GBP
- Report
- August 2025
- 150 Pages
Global
From €4408EUR$4,850USD£3,802GBP
- Report
- March 2024
- 382 Pages
Global
From €4499EUR$4,950USD£3,880GBP
- Report
- September 2023
- 160 Pages
Global
From €4226EUR$4,650USD£3,645GBP
- Report
- April 2025
Global
From €4454EUR$4,900USD£3,841GBP
- Report
- March 2025
- 96 Pages
Global
From €5408EUR$5,950USD£4,664GBP
- Report
- October 2023
- 87 Pages
Global
From €4499EUR$4,950USD£3,880GBP
- Report
- February 2024
- 116 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- February 2024
- 90 Pages
Argentina
From €4317EUR$4,750USD£3,723GBP
- Report
- February 2024
- 115 Pages
Global
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 68 Pages
Japan
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 71 Pages
North America
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 75 Pages
Italy
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 89 Pages
Saudi Arabia
From €4317EUR$4,750USD£3,723GBP
- Report
- April 2023
- 81 Pages
Spain
From €4317EUR$4,750USD£3,723GBP

Sacral nerve stimulation (SNS) is a type of neuromodulation therapy used to treat a variety of neurological conditions. It involves the implantation of a small device that sends electrical signals to the sacral nerve, which is located near the tailbone. The device is used to reduce symptoms such as urinary and fecal incontinence, chronic pelvic pain, and overactive bladder. It is also used to treat certain types of constipation.
SNS is a minimally invasive procedure that is typically performed in an outpatient setting. It is considered a safe and effective treatment option for many patients. The device is programmed to deliver electrical signals to the sacral nerve, which can help reduce symptoms and improve quality of life.
The SNS market is a growing segment of the neurology devices industry. It is expected to continue to grow as more patients seek out this treatment option. Companies in the SNS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less Read more